Sme-Migration (4)
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Beta Drugs Limited's equity shares are being listed on the NSE Main Board following migration from the SME Emerge platform, with … | |||||||||||||||
Beta Drugs Limited's equity shares are being listed on the NSE Main Board following migration from the SME Emerge platform, with shareholding pattern as of November 13, 2025.
| |||||||||||||||
Shareholding pattern filing for Modis Navnirman Limited in connection with its migration from BSE SME platform to BSE Mainboard, showing … | |||||||||||||||
Shareholding pattern filing for Modis Navnirman Limited in connection with its migration from BSE SME platform to BSE Mainboard, showing promoter holding of 63.79% and public shareholding of 36.21%.
| |||||||||||||||
Shareholding pattern filing for Modis Navnirman Limited (Scrip Code: 543539) dated November 7, 2025, in connection with its migration from … | |||||||||||||||
Shareholding pattern filing for Modis Navnirman Limited (Scrip Code: 543539) dated November 7, 2025, in connection with its migration from BSE SME to BSE Mainboard.
| |||||||||||||||
BSE revises unified eligibility criteria for SME companies migrating to Main Board and companies from other exchanges seeking direct … | |||||||||||||||
BSE revises unified eligibility criteria for SME companies migrating to Main Board and companies from other exchanges seeking direct listing.
| |||||||||||||||